MyFinsight
Home
Blog
About
Contact
Download
Download image
Manufactured Product Other
$440,033K
ALYFTREK
$196,933K
TRIKAFTAKAFTRIO
$2,553,033K
Product
$3,190,000K
Product revenues, net
$3,190,000K
Other expense, net
$6,500K
Interest income
$121,900K
Income (loss) from
operations
$1,205,900K
Total costs and
expenses
$1,984,100K
Income before
provision for income taxes
$1,331,000K
Interest expense
$3,300K
Change in fair value of
contingent consideration
$900K
Selling, general and
administrative expenses
$487,000K
Acquired in-process
research and development...
$56,500K
Research and development
expenses
$973,700K
Cost of sales
$466,000K
Income (loss)
$1,191,100K
Provision for income taxes
$139,900K
Back
Back
Income Statement
source: myfinsight.com
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)